2018
$22M
from 4 investors over 4 rounds
Stipe Therapeutics raised $22M on September 30, 2019
Investors: Novo Holdings, Arix Bioscience plc and Wellington Partners
Stipe Therapeutics raised undisclosed on January 1, 2018
Investors: BioInnovation Institute